Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Gastrointestinal Neoplasms × Dietary Supplements × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 7 Malnutrition 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Surgery--Complications 1 Peptic Ulcer 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Motor Activity 1 Malabsorption Syndromes 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced Head and Neck Carcinoma 1 Inflammatory Bowel Diseases 1 Infections 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Esophagitis 1 Duodenal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Cachexia 1

Interventions

Surveys and Questionnaires 9 Endoscopic Mucosal Resection 5 Educational Status 5 Standard of Care 4 Diet Therapy 3 Blood Specimen Collection 3 Referral and Consultation 2 Quality of Life 2 Practice Guidelines as Topic 2 Palliative Care 2 Magnetic Resonance Spectroscopy 2 Interviews as Topic 2 Control Groups 2 Aprepitant 2 Acceptance and Commitment Therapy 2 vandetanib 1 fosaprepitant 1 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Weights and Measures 1 Tomography, X-Ray Computed 1 Therapeutics 1 Surgical Instruments 1 Sunitinib 1 Sorafenib 1 Sampling Studies 1 Restraint, Physical 1 Remote Patient Monitoring 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03445260 2021-09-02

PROGRESS

Hamilton Health Sciences Corporation

Phase NA Completed

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡